<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04522219</url>
  </required_header>
  <id_info>
    <org_study_id>2020-000993-27</org_study_id>
    <nct_id>NCT04522219</nct_id>
  </id_info>
  <brief_title>Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion</brief_title>
  <acronym>AGATA</acronym>
  <official_title>Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion: a Prospective Comparative Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical diagnosis of adnexal torsion is difficult because the symptomatology is dominated by&#xD;
      abrupt onset pelvic pain, an aspecific sign which does not allow a diagnosis of certainty to&#xD;
      be made.&#xD;
&#xD;
      To confirm the diagnosis, the reference examination is pelvic ultrasound with Doppler flow&#xD;
      analysis. However, its intake is low, its sensitivity varies from 46 to 73% depending on the&#xD;
      studies. Other imaging techniques have been considered, such as MRI, with a sensitivity far&#xD;
      superior to ultrasound, but its difficult accessibility, in particular in the context of an&#xD;
      emergency, makes it unusable in clinical practice.&#xD;
&#xD;
      The use of ultrasound with the injection of an ultrasound contrast agent, strict&#xD;
      intravascular, seems to be an interesting technique to assess the perfusion parameters of the&#xD;
      ovary and improve the diagnostic sensitivity of the adnexal torsion. Its interest has already&#xD;
      been demonstrated in the diagnosis of testicular torsion in animals but to date, no study has&#xD;
      evaluated its contribution in adnexal torsion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective is to evaluate the diagnostic performance of contrast enhanced&#xD;
      ultrasound for the diagnosis of adnexal torsion in women with suspected adnexal torsion.&#xD;
&#xD;
      The secondary objectives are:&#xD;
&#xD;
        1. To describe the perfusion parameters of the ovaries by contrast enhanced ultrasound&#xD;
&#xD;
        2. To compare performance diagnosis of contrast ultrasound and bidimensional Doppler for&#xD;
           the detection of adnexal torsion.&#xD;
&#xD;
        3. To describe the perfusion parameters of the ovarian as a function of the degree of&#xD;
           adnexal torsion.&#xD;
&#xD;
        4. To compare perfusion parameters before and after ovarian detorsion&#xD;
&#xD;
        5. To describe perfusion parameters of the ovarian by using MicroVascular Flow technique&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 13, 2021</start_date>
  <completion_date type="Anticipated">April 14, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 13, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Phase 3b, pilot, prospective, Case-Control study</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Signal intensity measurement</measure>
    <time_frame>through study completion, on average of 36 months</time_frame>
    <description>to assess sensitivity, specificity, positive and negative predictive value of contrast enhanced ultrasound for detection of adnexal torsion in women with suspected adnexal torsion with realization of ROC curves</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vascularization of the ovaries on contrast enhanced ultrasound.</measure>
    <time_frame>through study completion, an average of 36 months</time_frame>
    <description>Measurement of perfusion parameters of the suspected ovarian torsion and the contralateral ovary if available:</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diagnostics performance</measure>
    <time_frame>through study completion, an average of 36 months</time_frame>
    <description>Measurement of signal intensities to assess sensibility and specificity of contrast enhanced ultrasound and bidimensional (2D) Doppler.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vascularization of the ovaries according to the degree of torsion</measure>
    <time_frame>through study completion, an average of 36 months</time_frame>
    <description>Comparison of perfusion parameters of the ovary with the degree of torsion. The degree of torsion is defined by the number of twists (number of turns around the axis) detected during the surgical procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vascularization of the ovaries before and after detorsion</measure>
    <time_frame>through study completion, an average of 36 months</time_frame>
    <description>Measurement of signal intensities before and after ovarian detorsion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Micro Vascular Flow technique</measure>
    <time_frame>through study completion, an average of 36 months</time_frame>
    <description>Measurement of signal intensities obtained by Micro Vascular Flow technique</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Adnexal Torsion</condition>
  <arm_group>
    <arm_group_label>Case group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diagnosis of adnexal torsion confirmed by the surgical intervention: woman allocated to case group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diagnosis of adnexal torsion not confirmed by the surgical intervention: woman allocated to control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Contrast enhanced ultrasound</intervention_name>
    <description>Acquisition of contrast enhanced ultrasound. Contrast agent: SonoVue®: Hexafluoride (SonoVue®, injectable solution to solubilisate, 8µg/mL) is injected in all patients</description>
    <arm_group_label>Case group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Woman over 18 years old&#xD;
&#xD;
          -  Woman affiliated to a social security&#xD;
&#xD;
          -  Woman having received complete information on the organization of the research and&#xD;
             having given her informed consent in written form.&#xD;
&#xD;
          -  Planned surgical intervention for suspected adnexal torsion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under a measure of legal protection,&#xD;
&#xD;
          -  Contraindication to contrast injection Hypersensitivity to sulfur hexafluoride or any&#xD;
             of the other ingredients, history of cardiac disease, respiratory distress syndrome,&#xD;
             severe pulmonary hypertension..&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charline BERTHOLDT</last_name>
    <role>Study Chair</role>
    <affiliation>Centre Hospitalier Régional Universitaire de Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charline BERTHOLDT</last_name>
    <phone>+3383344312</phone>
    <email>c.bertholdt@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charline BERTHOLDT</last_name>
      <email>c.bertholdt@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 21, 2020</study_first_submitted>
  <study_first_submitted_qc>August 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2020</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>BERTHOLDT Charline</investigator_full_name>
    <investigator_title>Principal investigator (Obstetrician, Medical Doctor)</investigator_title>
  </responsible_party>
  <keyword>adnexal</keyword>
  <keyword>torsion</keyword>
  <keyword>ovarian</keyword>
  <keyword>contrast enhanced ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Torsion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

